Moxifloxacin
VIGAMOX contains the active substance moxifloxacin. Moxifloxacin belongs to a class of antibiotics called fluoroquinolones, used to treat bacterial eye infections. VIGAMOX is used to treat bacterial eye infections (conjunctivitis).
Consult a doctor or pharmacist:
As with any other antibiotic, long-term use of VIGAMOX may lead to the development of other infections.
Tell your doctor or pharmacist about all medicines the patient is taking, including those obtained without a prescription.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor before using VIGAMOX.
For a short time after administering VIGAMOX, vision may be blurred. Do not drive or operate machinery until vision returns to normal.
Always use this medicine exactly as your doctor or pharmacist has told you. If you are not sure, ask your doctor or pharmacist.
Adults, including the elderly and children: 1 drop into the affected eye(s), 3 times a day (morning, afternoon, and evening). VIGAMOX can be used in children, patients over 65 years, and patients with kidney and liver diseases. The use of this medicine is not recommended in newborns, as only limited information is available on its use in these patients. This medicine should be used in both eyes only if advised by a doctor. VIGAMOX is for eye use only. The infection usually resolves within 5 days. If the patient does not observe improvement, they should contact their doctor. The use of drops should be continued for a further 2-3 days or as advised by the doctor.
1
2
3
If the drop does not get into the eye, try again.
If you use more VIGAMOX than you should:rinse your eyes with warm water. Do not put in another drop until it is time for your next regular dose.
If you accidentally swallow VIGAMOX, consult your doctor or pharmacist for advice.
If you miss a dose of VIGAMOX:continue using the medicine as planned. Do notuse a double dose to make up for a missed dose.
If you are using other eye drops, wait at least 5 minutes between using VIGAMOX and the other drops.
Like all medicines, VIGAMOX can cause side effects, although not everybody gets them.
It is usually possible to continue using the drops, unless the side effects are serious or if the patient experiences severe allergic reactions.
inform their doctor right away:swelling of the hands, feet, ankles, face, lips, mouth, or throat, which may cause difficulty swallowing or breathing, rash or hives, large blisters, wounds, or ulcers.
(may affect up to 1 in 10 people)
Eye disorders:eye pain, eye irritation
(may affect up to 1 in 100 people)
Eye disorders:dry eye, eye itching, eye redness, inflammation of the surface of the eye or scarring, broken blood vessel in the eye, abnormal sensation in the eye, disorders of the eyelids, itching, redness, or swelling
General disorders:headache, unpleasant taste
(may affect up to 1 in 1000 people)
Eye disorders:corneal disease, blurred or impaired vision, conjunctivitis or eye infection, eye strain, eye swelling
General disorders:vomiting, discomfort in the nose, feeling of lumps in the throat, decreased iron levels in the blood, abnormal liver test results, skin sensation disorders, pain, throat irritation
(cannot be estimated from the available data)
Eye disorders:eye infection, clouding of the eye surface, corneal swelling, deposits on the eye surface, increased eye pressure, scratching on the eye surface, eye allergy, eye discharge, increased tear production, sensitivity to light
General disorders:shortness of breath, irregular heartbeat, dizziness, worsening of allergic symptoms, itching, rash, redness of the skin, nausea, and hives.
If you experience any side effects, including any side effects not listed in the leaflet, tell your doctor, pharmacist, or nurse. You can also report side effects directly to the Department of Medicinal Product Monitoring, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
There are no special storage precautions.
To prevent infections, the bottle should be discarded 4 weeks after it is first opened.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
The active substance ismoxifloxacin.
One ml of eye drops contains 5 mg of moxifloxacin (as 5.45 mg of moxifloxacin hydrochloride). One drop contains 190 micrograms of moxifloxacin.
The other ingredients are:sodium chloride, boric acid, purified water.
Additionally, the medicine contains small amounts of sodium hydroxide and/or hydrochloric acid to adjust its pH.
The medicine is a liquid (clear, yellowish-green solution), supplied in cartons containing a 5 ml LDPE bottle with a screw cap.
For more detailed information, consult the marketing authorization holder or parallel importer.
Novartis Farma – Produtos Farmacêuticos, S.A.
Avenida Professor Doutor Cavaco Silva, n.º 10E, Taguspark
2740-255 Porto Salvo, Portugal
Novartis Farmacéutica, S.A.
Gran Via de les Corts Catalanes, 764, 08013 Barcelona, Spain
Delfarma Sp. z o.o.
ul. Św. Teresy od Dzieciątka Jezus 111
91-222 Łódź
Delfarma Sp. z o.o.
ul. Św. Teresy od Dzieciątka Jezus 111
91-222 Łódź
Portuguese marketing authorization number, country of export: 5218961
This medicine is authorized in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) under the following names:
MOXIFLOXACIN ALCON:
Germany
KANAVIG:
Belgium, Luxembourg
VIGAMOX:
Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, Greece, Iceland, Latvia, Lithuania, Malta, Netherlands, Poland, Portugal, Romania, Spain, Slovakia, Slovenia, Sweden, Hungary, Italy
MOXIVIG:
United Kingdom (Northern Ireland)
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.